Adopting a new approach to treat refractory or resistant viral infections in solid organ transplant recipients

Transpl Infect Dis. 2023 Dec;25(6):e14161. doi: 10.1111/tid.14161. Epub 2023 Oct 4.

Authors

Varvara Probst^{1

2}, Sanya J Thomas^{1

2}, Christopher P Ouellette^{1

2}

Affiliations

¹ Host Defense Program, Division of Infectious Diseases, Nationwide Children's Hospital, Columbus, Ohio, USA.
² The Ohio State University College of Medicine and Public Health, Columbus, Ohio, USA.

PMID: 37793055
DOI: 10.1111/tid.14161

No abstract available

Publication types

Editorial

MeSH terms

Antiviral Agents / therapeutic use
Humans
Organ Transplantation* / adverse effects
Transplant Recipients
Virus Diseases* / drug therapy

Substances

Antiviral Agents